Patents
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
02/2012
02/22/2012EP2419401A2 GAMMA-AMINO-BUTYRIC ACID DERIVATIVES AS GABAb RECEPTOR LIGANDS
02/22/2012EP2076497B1 Aminomethyl-4-imidazoles
02/22/2012EP1841750B1 Heterocyclic modulators of the glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof
02/22/2012EP0986384B1 Inhibitors of protein isoprenyl transferases
02/22/2012CN102358739A Synthetic method for imidazole[1,2-a]pyridine and 2-butyl-5-chloro-1H-imidazole-4-carboxaldehyde compounds
02/22/2012CN101607942B 一类抗肿瘤化合物及其制备方法 A class of anti-cancer compounds and methods
02/22/2012CN101492416B 影响葡糖激酶的化合物 Effect of compound of glucokinase
02/22/2012CN101454329B 取代苯基乙炔基金-含氮杂环卡宾络合物 Substituted phenyl acetylene Fund - nitrogen-containing heterocyclic carbene complexes
02/21/2012US8119819 Malonyl-CoA decarboxylase inhibitors useful as metabolic modulators
02/21/2012US8119680 α-Haloketone derivatives of imidazolyl-substituted aromatic compounds and compounds prepared therefrom
02/21/2012US8119679 Method for preparation of 2,4-dinitroimidazole which is an intermediate for insensitive meltcastable molecular explosive
02/21/2012US8119678 Compounds, compositions and methods
02/21/2012US8119674 4-phenylimidazole-2-thione tyrosinase inhibitors and pharmaceutical/cosmetic applications thereof
02/21/2012US8119665 Aryl imidazoles and related compounds as C5a receptor modulators
02/16/2012WO2012020742A1 Novel heterocyclic derivatives and pharmaceutical composition containing same
02/16/2012WO2012020738A1 Heterocyclic compound and use thereof
02/16/2012WO2012020133A1 Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
02/16/2012WO2012020130A1 Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
02/16/2012US20120040985 Triazole and imidazole derivatives for use as tgr5 agonists in the treatment of diabetes and obesity
02/16/2012US20120040948 Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
02/16/2012US20120040947 Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
02/16/2012CA2806658A1 Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
02/16/2012CA2806644A1 Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
02/16/2012CA2806643A1 Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
02/15/2012EP2417225A2 Process for removing metals from hydrocarbons
02/15/2012EP2417119A2 No-carrier-added nucleophilic ýf-18¨fluorination of aromatic compounds
02/15/2012EP2417109A2 Process for the preparation of chalcogene compounds
02/15/2012EP2417106A1 Process for preparing pyrrolidinium salts
02/15/2012EP2417101A1 Indane derivatives
02/15/2012EP2417061A2 Molecular sieves and related methods and structure directing agents
02/15/2012EP2416657A1 Substituted di-arylhydantoin and di-arylthiohydantoin compounds and methods for use thereof
02/15/2012CN1847228B 奥扎格雷鸟氨酸盐及其注射剂型 Orszag Thunderbird acid salts and injectable forms
02/15/2012CN102351798A 1-hydroxymethyl-5,5-dimethylhydantion
02/15/2012CN102351797A Production device and method of hydantoin
02/15/2012CN102351796A Production process of imidazole ionic liquid
02/14/2012US8115027 NPY Y5 antagonist
02/09/2012WO2011156921A3 Catalyst ligands, catalytic ligand complexes and polymerization processes using same
02/09/2012US20120035351 Volatile Imidazoles and Group 2 Imidazole Based Metal Precursors
02/09/2012US20120035235 Methods of treating alpha adrenergic mediated conditions
02/09/2012US20120035231 Specific diarylhydantoin and diarylthiohydantoin compounds
02/09/2012US20120035176 Analogs of 3-o-acetyl-11-keto-beta-boswellic acid
02/09/2012US20120035108 Spray base material including low-molecular gelator
02/08/2012EP2415759A1 CETP inhibitors
02/08/2012EP2415758A1 Fluorine-containing n-alkyl sulfonyl imide compound, manufacturing method therefor, and method of manufacturing an ionic compound
02/08/2012EP2098515B1 Substituted carbinol compound
02/08/2012CN1934091B 治疗神经变性障碍的咪唑化合物 Treatment of neurodegenerative disorders imidazole compound
02/08/2012CN102348694A Imidazole derivatives
02/08/2012CN102344414A Method for preparing ionic liquid polyoxometalate nanorods by room temperature solid-phase chemical reaction
02/08/2012CN102344413A Volatile imidazoles and group 2 imidazole based metal precursors
02/08/2012CN102344220A Method for treating metronidazole waste water
02/08/2012CN101415687B 鞘氨醇-1-磷酸结合抑制物质 Sphingosine-1-phosphate binding-inhibiting substance
02/08/2012CN101374518B 新型组氨酸衍生物 The new histidine derivatives
02/08/2012CN101367825B 双卡宾钳型稀土配合物及制法及其在双烯烃高顺1,4选择性聚合中的应用 Rare Earth Clamp Double carbene complexes and manufacturing method and its application in high cis 1,4-diene-selective polymerization
02/08/2012CN101092402B 磺酰脲类化合物及其医药用途 Sulfonylurea compounds and their pharmaceutical use
02/07/2012US8110594 Use against hormone refractory prostate cancer; 1-(3-trifluoromethyl-4-cyanophenyl)-2-thioxo-3-(substituted phenyl)-imidazolidin-5-one and spiro ring derivatives thereof; androgen receptor antagonists with minimal agonist activity
02/07/2012US8110593 Phenoxymethyl imidazoline derivatives and their use as pesticides
02/07/2012CA2529269C Improved pharmaceutical drug candidates and methods for preparation thereof
02/07/2012CA2524222C N.epsilon. and/or n.alpha. derivatized, metal and organic protected l-histidine for coupling to biomolecules for highly efficient labeling with [m(oh2)3(co)3]+ by fac coordination
02/07/2012CA2486836C Multi-substituted imidazolines and method of use thereof
02/02/2012WO2012015878A1 Maintaining antiwear performance and improving deposit formation resistance of turbine oils
02/02/2012WO2012015873A1 Method for improving the deposit formation resistance performance of turbine oils containing amine antioxidants
02/02/2012WO2012015324A1 Process for the synthesis of substituted urea compounds
02/02/2012WO2012014699A1 Therapeutic agent for neurological diseases
02/02/2012WO2012014127A1 5-lipoxygenase inhibitors
02/02/2012US20120029203 Synthesis Of Triethylenetetramines
02/02/2012US20120029041 2-aryl imidazoline derivatives
02/02/2012US20120028981 Kinase Knockdown Via Electrophilically Enhanced Inhibitors
02/02/2012US20120028977 Subunit Selective NMDA Receptor Potentiators For The Treatment Of Neurological Conditions
02/02/2012US20120028249 Anthraquinone based near ir emitting compounds and uses thereof
02/02/2012CA2806766A1 Therapeutic agent for neurological diseases
02/02/2012CA2806701A1 Process for the synthesis of substituted urea compounds
02/01/2012EP2411352A2 Antiviral compounds and uses thereof
02/01/2012EP1531810B1 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
02/01/2012CN102336714A Hydantoin ibuprofen derivative and synthetic method and application thereof
02/01/2012CN102336713A Synthesis method for double-tagging 2-NP-AHD-(13C, 15N2)
02/01/2012CN102336712A Nitrogen-containing heterocyclic ring derivatives synthesized by transition metal salt induced intermolecular cyclization and preparation method thereof
02/01/2012CN102336677A Chiral valine radical ionic liquid and preparation method thereof
02/01/2012CN102030712B 二甲基海因的生产装置 DMH's production unit
02/01/2012CN101528709B 对痕量胺相关受体有亲和性的氨基甲基-2-咪唑类 The trace amine associated receptors have affinity for the amino-methyl-2-imidazole
01/2012
01/31/2012US8106217 anion is bis(pentafluoroethyl)phosphinic imide [(C2F5)2P(O)]2N- ; solvents for electrochemical reactions; salt formation
01/31/2012US8106213 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them
01/26/2012WO2012011840A1 Cyclic n,n'-diarylthioureas and n,n'-diarylureas as androgen receptor antagonists, anti-cancer agent, method for producing and using same
01/26/2012US20120022269 Fluorine-containing n-alkylsulfonylimide compound, manufacturing method therefor, and method of manufacturing an ionic compound
01/26/2012US20120022257 Processes for preparing hiv reverse transcriptase inhibitors
01/26/2012US20120022083 Small molecule modulators of cell adhesion
01/26/2012US20120020915 Compounds and Methods for Treating Cancer and Diseases of the Central Nervous System
01/26/2012CA2806051A1 Cyclic n,n'-diarylthioureas and n,n'-diarylureas as androgen receptor antagonists, anticancer agent, method for producing and using same
01/25/2012EP2408751A1 Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof
01/25/2012EP1310494B1 PPAR (delta) ACTIVATORS
01/25/2012CN102333757A N-acyl anthranilic acid derivative or salt thereof
01/25/2012CN102329269A Synthesis of bionic creatininium chloride and catalytic polycondensation method for synthesizing high-molecular-weight polylactic acid
01/25/2012CN101611016B Talarazole metabolites
01/24/2012US8101779 Enantioselective synthesis of (+) and (–)-2-[1-(2,6-dichlorophenoxy)-ethyl]-1,3-diazacyclopent-2-ene
01/24/2012US8101778 Five-membered heterocycles useful as serine protease inhibitors
01/24/2012US8101777 Ionic liquids based on imidazolium salts incorporating a nitrile functionality
01/24/2012US8101749 Process for the preparation of onium salts with a tetrafluoroborate anion having a reduced halide content
01/24/2012US8101640 Antibacterial agents
01/24/2012US8101637 Alkynyl derivatives as modulators of metatropic glutamate receptors
01/24/2012CA2537832C Nonsedating a-2 agonist 1-(2,3-dimethyl-phenyl)-ethyl-1, 3-dihydro-imizadole-2-thione
01/24/2012CA2435687C Omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells
1 ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 ... 345